PFAROS step 2-application
Reference number | |
Coordinator | RISE Research Institutes of Sweden AB |
Funding from Vinnova | SEK 300 000 |
Project duration | July 2025 - October 2025 |
Status | Ongoing |
Venture | Global cooperation 2025 |
Call | Planning grant for international proposal 2025 |
Purpose and goal
The aim of this preparatory project is to strengthen the Stage 2 application, mainly by participating in the planned physical meeting in Brussels together with the predefined industrial consortium. The aim is to jointly refine the project idea and ensure a strong and competitive application. The ambition is not only to obtain funding, but also to lay the foundations for a project with well-coordinated activities, realistic timelines and clearly anchored expectations between the partners.
Expected effects and result
PFAS are used both in manufacturing and in some medical products. These substances are highly persistent and pose a risk to both humans and animals. The aim of the main project is to reduce the use of PFAS, and where possible, replace them completely in the production of medicines and medical devices - without compromising human health.
Planned approach and implementation
- Lead the work in one of the WPs of the main project. Plan activities in detail, include partners from the predefined industry consortium, budget, and schedule deliverables to seamlessly collaborate with the other WPs. - Mapping of what expertise, methods, and capabilities exist in the predefined industrial consortium, which are needed for the activities RISE leads to be able to deliver the set result goals and effects. - Part-financing of writing agency